SCHEMBL6379239

SCHEMBL6379239

COC(=O)c1ccc(OCCn2ccc3ccccc32)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.60
RAB9A P51151 4/20 0.60
NPC1 O15118 3/20 0.60
ALDH1A1 P00352 2/20 0.60
MEN1 O00255 1/20 0.60
KMT2A Q03164 1/20 0.60
MAPT P10636 3/20 0.58
MAPK1 P28482 3/20 0.56
TRPV1 Q8NER1 1/20 0.53
FFAR1 O14842 1/20 0.53
PPARG P37231 1/20 0.53
HTT P42858 3/20 0.52
LMNA P02545 3/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
TSHR P16473 2/20 0.52
TDP1 Q9NUW8 1/20 0.51
TP53 P04637 2/20 0.51
HSD17B10 Q99714 1/20 0.51
KDM4E B2RXH2 1/20 0.50
HPGD P15428 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1608799 0.85 MAPT (0.56) SMN1; SMN2RAB9ANPC1ALDH1A1MEN1
SCHEMBL6380447 0.83 FFAR1 (0.56) SMN1; SMN2RAB9ANPC1ALDH1A1MEN1
SCHEMBL6380266 0.81 PPARG (0.54) SMN1; SMN2RAB9ANPC1ALDH1A1MEN1
SCHEMBL6381119 0.80 NPC1 (0.49) SMN1; SMN2RAB9ANPC1ALDH1A1MEN1
SCHEMBL6383661 0.80 PPARG (0.63) SMN1; SMN2RAB9ANPC1ALDH1A1MEN1
SCHEMBL30696517 0.80 KDM4E (0.52) SMN1; SMN2ALDH1A1MAPTMAPK1TRPV1
SCHEMBL1608367 0.79 ALDH1A1 (0.51) SMN1; SMN2ALDH1A1MAPTMAPK1TRPV1
SCHEMBL6380437 0.79 PPARG (0.53) SMN1; SMN2RAB9ANPC1ALDH1A1MEN1
SCHEMBL3496372 0.79 HDAC8 (0.69) SMN1; SMN2RAB9ANPC1ALDH1A1MEN1
SCHEMBL3379870 0.78 SMN1; SMN2 (0.47) SMN1; SMN2RAB9ANPC1ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050032787-A1 Pheny (alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity SIGMA-TAU INDUSTRIES FARMACEUTICHE RIUNITE S.P.A. (IT) 2005-02-10 US claimed
US-20050032787-A1 Pheny (alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity SIGMA-TAU INDUSTRIES FARMACEUTICHE RIUNITE S.P.A. (IT) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032787-A1 Pheny (alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity LIPC, CPT1A, GPR119 SMN1; SMN2 4124/4885RAB9A 1357/4885NPC1 312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.